MAPK3 and Marfan syndrome: These data suggested that TGF-β-driven ERK1/2 activation contributes to aneurysmal formation in MFS and that antagonism of this pathway may be therapeutically useful, but further studies are also necessary to examine the involvement of other noncanonical signaling components, such as TRAF6-TAK1 pathway [37,38], in various disease states.